Monsanto Roundup Lawsuit

Sunday, August 29, 2010

Average Paxil Birth Defect Settlement $1.2 Million

Image: naturalcommunitiesmag.com


Lawyers and Settlements is reporting that the average settlement in the Paxil birth defect cases works out at approximately $1.2 million for each family involved, that's around £644,000 in English money.

By settling cases Glaxo and the claimants come to an agreement that nobody accepts liability. In other words, nobody is at fault for these children who were born with heart defects.

The $1.2 million should go a long way in helping these poor children get the medical treatment they so richly deserve. It does not, however, bring those responsible for this abomination to task.

Once again money is thrown at the problem and the culprit [do I have to add 'alleged' here?] walks free.

When are criminal charges going to be brought against pharmaceutical companies for withholding valuable data?

Are the FDA or MHRA going to do anything about this? Of course not - where's the proof? Locked and sealed as part of the settlement agreement. So, thankfully for the FDA and MHRA, no investigation is needed and they can go about their daily routine busting Joe Bloggs for selling a bunch of fake Viagra pills down at the local gymnasium.

Will the MHRA now have to admit that Paxil is a teratogen? Of course not, because GlaxoSmithKline, by ordering documents sealed as part of the settlement, don't have to inform them.

Doncha just love the way the drugs you and I take are regulated!


Later this year...or early next year, GlaxoSmithKline will be in the High Court in London, UK, defending a group action brought against them that claims that consumers had difficulty withdrawing from their product, Seroxat [known as Paxil in the US]

The claims are being pursued under the Consumer Protection Act (CPA) 1987. The CPA provides for a non-fault based liability if the product is found to be defective and to have caused injury as a result.

Despite Glaxo taking a legal charge of £1.6 billion earlier this year to settle cases in the US regarding Seroxat, it would appear that they are not going to do the same with British consumers of their drug.

Let battle commence. I, for one, can't wait to see those items of disclosure.

Fid

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING
Post a Comment